Verisys

JANUARY 18, 2022

Primary source verification must be done to confirm a provider’s education, professional license and certifications, medical training, work history, references, and more. Provider information should be continuously monitored for any changes to exclusion or license status. ISO 27001:2013 (information security).

Licensing 52

Licensing Medicaid Medicaid Governance 52

Provider Trust

MAY 18, 2022

Moon , for submitting claims while excluded from March 2006 through July 2013. This action was in addition to the 2018 settlement and sought these additional actions alleging that the clinics named in the complaint suffered significant gaps in licensing and supervision of therapists during the relevant time period.

Compliance 52

Compliance Due Diligence Medicaid Medicaid 52

Hall Render

DECEMBER 13, 2024

Care Taps Health Net Exec as New CEO COLORADO Aurora’s Fitzsimons plans development opportunities on 60 acres Boulder drug discovery co. 3 in the U.S. for maternity care Healthcare Shifts Driving Demand For Outpatient Facilities In Denver Insider Breach, Email Attacks Net $1.7M sold for $4.1B TEXAS Bivacor to implant more U.S.

US Department of Health and Human Services 40

US Department of Health and Human Services Nursing Homes Hospitals Nurses 40

Hall Render

JULY 22, 2022

cancer, cardio lab fraud. Board suspends nurse’s license 17 months after arrest in stabbing incident. New York confirms 1st national polio case since 2013. HHS orders additional 2.5 million doses of monkeypox vaccine. Supreme Court clarifies liability standard for physicians prescribing controlled substances. NORTH CAROLINA.

COVID-19 40

COVID-19 Nursing Homes Nurses Hospitals 40

Drug & Device Law

DECEMBER 29, 2023

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Equally bad, Hrymoc effectively read a New Jersey statute, §2A:58C-5(c), which precludes punitive damages where a “device” was “licensed” by the FDA, out of existence. The G/N MDL was created in 2013 and mostly settled in 2016. Monsanto Co. , 4th 851 (6th Cir.

FDA 105

FDA US Department of Health and Human Services COVID-19 COVID-19 Vaccine 105

Drug & Device Law

FEBRUARY 2, 2023

2013); Massa v. Texas, unlike most states, enforces a strong statutory presumption that prescription medical product warnings complying with FDA requirements imposed by “pre-market approval or licensing of the product” are adequate as a matter of law. Novartis Pharmaceuticals Corp. , 2d 898, 909-10 (W.D. Genentech Inc. & Rem.

FDA 59

FDA Licensing Fraud 59

Drug & Device Law

MARCH 7, 2022

Here, Plaintiffs fail to supply factual support showing Defendant acted with “oppression, fraud, or malice,” relying instead upon conclusory allegations. Punitive damages are available when the evidence shows that the defendant acted with fraud, malice, or gross negligence. . . . [T]he Francis , 2013 WL 5603848, at *2 (D.N.J.

Fraud 59

Fraud FDA Licensing Pharmaceutical Industry 59